Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | PKM | P14618 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | HPGD | P15428 | 6/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140332 | 0.85 | POLB (0.65) | HTTCYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL14557079 | 0.84 | CXCR4 (0.52) | HTTCYP1A2CYP2D6KMT2APKM | |
| SCHEMBL3840545 | 0.82 | TLR8 (0.67) | HTTKMT2AMEN1KDM4EALDH1A1 | |
| SCHEMBL3137088 | 0.81 | TLR8 (0.68) | HTTCYP1A2CYP2D6ALDH1A1POLB | |
| SCHEMBL11350545 | 0.81 | CYP1A2 (0.44) | HTTCYP1A2CYP2D6KMT2APKM | |
| SCHEMBL14112988 | 0.81 | MEN1 (0.49) | HTTCYP1A2CYP2D6KMT2APKM | |
| SCHEMBL1104424 | 0.80 | KDM4E (0.62) | HTTCYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL12565557 | 0.80 | LMNA (0.56) | HTTCYP1A2CYP2D6KMT2AMEN1 | |
| SCHEMBL230641 | 0.80 | ALDH1A1 (0.70) | HTTCYP1A2CYP2D6KMT2APKM | |
| SCHEMBL3136462 | 0.80 | TLR8 (0.68) | HTTCYP1A2CYP2D6ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 310 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110845910-A | OLED ink for ink-jet printing and preparation method thereof | 成都新柯力化工科技有限公司 | 2020-02-28 | — | — | CN | claimed |
| CN-108101935-A | Silane of one kind structure containing benzimidazole and preparation method thereof | 烟台大学 | 2018-06-01 | — | — | CN | claimed |
| US-5738969-A | WATER INSOLUBLE COMPOUND HAVING MERCAPTO OR THIONE GROUP, AND SULFONATED STYRENE-CONTAINING POLYMER | MITSUBISHI PAPER MILLS LIMITED (JP) | 1998-04-14 | — | — | US | claimed |
| US-6423486-B1 | — | — | None | — | — | US | disclosed |
| US-20250051320-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-02-13 | — | — | US | disclosed |
| US-11932635-B2 | CRBN ligands and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2024-03-19 | — | — | US | disclosed |
| CN-116550475-A | Sphalerite collecting agent and preparation method and application thereof | 广西大学 | 2023-08-08 | — | — | CN | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-07-27 | — | — | US | disclosed |
| US-11512080-B2 | CRBN ligands and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2022-11-29 | — | — | US | disclosed |
| US-5391457-A | For silver complex diffusion transfer processing in presence of a triazole, oxadiazole type compound; wear resistance of plates; good ink receptivity; free from waste solution disposal | FUJI PHOTO FILM CO., LTD (JP) | 1995-02-21 | — | — | US | disclosed |
| US-5321053-A | Curable mixture of vinyl monomer containing acidic group and photoinitiator | KURARAY CO., LTD. (JP) | 1994-06-14 | — | — | US | disclosed |
| EP-0559228-A1 | Photothermographic elements | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5153097-A | LIGHT-SENSITIVE MATERIAL FOR LITHOGRAPHIC PRINTING PLATE AND PROCESS FOR MAKING PRINTING PLATE | MITSUBISHI PAPER MILLS LIMITED (JP) | 1992-10-06 | — | — | US | disclosed |
| EP-0155812-B1 | DENTAL COMPOSITIONS | KURARAY CO., LTD. (JP) | 1991-09-11 | — | — | EP | disclosed |
| EP-0087176-B1 | METHOD FOR THE PREPARATION OF A PLANOGRAPHIC PRINTING PLATE | AGFA-GEVAERT N.V. (BE) | 1987-07-01 | — | — | EP | disclosed |
| US-4563410-A | NICKEL SULFIDE; HYDROPHOBIZING SILVER IMAGE | AGFA-GEVAERT N.V. (BE) | 1986-01-07 | — | — | US | disclosed |
| US-4353981-A | CONTAINING WATER SOLUBLE COMPOUND OF RHODIUM, IRIDIUM OR GOLD; STORAGE STABILITY | MITSUBISHI PAPER MILLS, LTD. (JP) | 1982-10-12 | — | — | US | disclosed |
| US-4230792-A | COMPLEXING SILVER WITH THIOL OR THIONE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1980-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234950-A1 | CRBN LIGANDS AND USES THEREOF | CRBN, CRKL, ERBB3 | HTT 1125/4885CYP1A2 4670/4885CYP2D6 4808/4885 |
| US-11932635-B2 | CRBN ligands and uses thereof | CRBN, CRKL, ERBB3 | HTT 1125/4885CYP1A2 4670/4885CYP2D6 4808/4885 |
| US-20250051320-A1 | CRBN LIGANDS AND USES THEREOF | CRBN, CRKL, ERBB3 | HTT 1125/4885CYP1A2 4670/4885CYP2D6 4808/4885 |
| US-11512080-B2 | CRBN ligands and uses thereof | CRBN, CRKL, ERBB3 | HTT 1125/4885CYP1A2 4670/4885CYP2D6 4808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.